Hannah M. Wexler
Greater Los Angeles Veterans Administration Healthcare System
University of California
Los Angeles
CA 90073
USA
Name/email consistency: high
- Characteristics of Bacteroides fragilis lacking the major outer membrane protein, OmpA. Wexler, H.M., Tenorio, E., Pumbwe, L. Microbiology (Reading, Engl.) (2009)
- Bacteroides: the good, the bad, and the nitty-gritty. Wexler, H.M. Clin. Microbiol. Rev. (2007)
- In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates. Wexler, H.M., Engel, A.E., Glass, D., Li, C. Antimicrob. Agents Chemother. (2005)
- In vitro activity of ertapenem: review of recent studies. Wexler, H.M. J. Antimicrob. Chemother. (2004)
- Characterization of omp200, a porin gene complex from Bacteroides fragilis: omp121 and omp71, gene sequence, deduced amino acid sequences and predictions of porin structure. Wexler, H.M., Read, E.K., Tomzynski, T.J. Gene (2002)
- Outer-membrane pore-forming proteins in gram-negative anaerobic bacteria. Wexler, H.M. Clin. Infect. Dis. (2002)
- In vitro activities of faropenem against 579 strains of anaerobic bacteria. Wexler, H.M., Molitoris, D., St John, S., Vu, A., Read, E.K., Finegold, S.M. Antimicrob. Agents Chemother. (2002)
- In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria. Wexler, H.M., Molitoris, D., Finegold, S.M. Antimicrob. Agents Chemother. (2000)
- Current susceptibility patterns of anaerobic bacteria. Wexler, H.M., Finegold, S.M. Yonsei Med. J. (1998)
- In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections. Wexler, H.M., Molitoris, E., Molitoris, D., Finegold, S.M. Antimicrob. Agents Chemother. (1998)